Gate CrossEx targets institutional capital fragmentation
Gate launched CrossEx in Beta in October 2025 to offer exchange-native cross-venue margin pooling with instant internal collateral movement across five exchanges.
Gate launched CrossEx in Beta in October 2025. The product offers cross-venue margin pooling that lets collateral move instantly between five supported centralized exchanges via internal settlement rather than on-chain transfers. A single funded account at Gate can act as margin across those venues, pooling profits and losses and reducing the need to pre-fund separate accounts on each exchange.
CrossEx supports more than 5,200 assets. Seven tokens-BTC, ETH, BNB, SOL, XRP, USDT and USDC-are eligible as shared margin collateral across the five connected venues. Collateral is credited and reallocated within Gate’s systems instead of being moved on blockchains, and P&L is aggregated into a unified margin pool so gains on one venue can back positions on another in real time.
The product is aimed at institutional trading desks that run books across multiple centralized exchanges. Under the standard model, desks must fund separate accounts on each exchange to meet worst-case margin requirements, with no netting across venues. On-chain transfers during volatile markets can take minutes or longer and can fail to arrive before exchanges trigger liquidations.
Gate CrossEx removes the on-chain rebalance step by letting Gate post margin where it is needed through internal credit. The platform’s internal settlement is intended to reduce delays between a margin call on one venue and collateral availability for that venue.
Gate outlines specific use cases for CrossEx. Cross-exchange arbitrage desks can net exposure across legs and avoid posting full margin on each venue; Gate’s internal modeling estimates roughly 40% capital savings for a two-venue basis trade versus separately funded accounts. Desks that trade across venues can aggregate volume into a single fee-tier calculation across the five venues, and accounts that run low-margin volume to maintain VIP tiers can route genuine strategy flow through CrossEx to support a single VIP ladder at Gate.
Gate published a growth index for CrossEx covering November 2025 through April 2026, with November set to an index base of 100. The index was flat for the initial two months of Beta, rose roughly tenfold in January, increased modestly in February, and showed larger step-ups in March and April. Gate described the pattern as tranche-based onboarding; the company did not disclose absolute dollar assets under management tied to the index.
Open questions remain about the product’s risks and business model. Gate must act as a credit intermediary for positions held on competitor exchanges, a role that introduces operational, counterparty and legal exposure. The current five-venue configuration covers a portion of institutional volume but excludes other exchanges used by some trading books. It is not yet clear whether other centralized exchanges will deploy similar cross-venue margin products or how Gate will monetize the margin-and-credit layer at scale; Gate has published user-facing fee tiers but has not detailed the economics of credit intermediation.
Gate positioned CrossEx as a netting layer at the exchange level, allowing existing routing systems to choose venues for execution while a pooled margin layer supports those orders. Gate reported early Beta uptake by multi-venue professional desks; wider adoption will depend on expansion of supported venues, further product disclosures and competitive responses.
The content on The Coinomist is for informational purposes only and should not be interpreted as financial advice. While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, or reliability of any content. Neither we accept liability for any errors or omissions in the information provided or for any financial losses incurred as a result of relying on this information. Actions based on this content are at your own risk. Always do your own research and consult a professional. See our Terms, Privacy Policy, and Disclaimers for more details.








